Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG vs. Basiliximab to prevent delayed graft function in kidney transplant
NCT02056938Phase 4Terminated
- Sponsor
- CHU de Nantes
- Start
- Jun 2014
- Primary completion
- Feb 2017
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of antithymocyte immunoglobulin in delayed graft function (DGF), sponsored by CHU de Nantes. Started Jun 2014; status: terminated.
02
Drugs
antithymocyte immunoglobulin
03
Conditions
delayed graft function (DGF)
Beyond the preview
Go deeper on NCT02056938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02056938.